HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The study of killer cell immunoglobulin-like receptor 3DL2 gene polymorphisms and pre-eclampsia].

AbstractOBJECTIVE:
To analyze a presumed association of gene polymorphism of killer cell immunoglobulin-like receptor three domains, long cytoplasmic tail, 2(KIR3DL2) gene with pre-eclampsia.
METHODS:
The KIR3DL2 gene A52G in exon 3 and C32T in exon 9 polymorphism were determined by polymerase chain reaction-restricted fragment length polymorphism (PCR-RFLP) in 95 pre-eclampsia and 91 normal pregnant women.
RESULTS:
There was significant difference between two group in exon 3 in terms of genotypes and allele (P < 0.05). There was a significant difference between two groups regarding the frequencies of exon 9 CC, CT and TT genotypes (P < 0.05). But no significant difference was found between mild pre-eclampsia and severe pre-eclampsia groups in terms of the two SNP loci (P > 0.05).
CONCLUSION:
The A52G polymorphism in exon 3 and the frequencies of C32T in exon 9 of KIR3DL2 gene polymorphism are associated with the pathogenesis of pre-eclampsia, But it has no correlation with the severity of preeclampsia.
AuthorsXiao-lan Wang, Wei-yuan Zhang, Qi Wang, Cheng-juan Sun
JournalZhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi) Vol. 89 Issue 21 Pg. 1468-71 (Jun 02 2009) ISSN: 0376-2491 [Print] China
PMID19953898 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, KIR3DL2
Topics
  • Alleles
  • Exons
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Polymorphism, Restriction Fragment Length
  • Pre-Eclampsia (genetics)
  • Pregnancy
  • Receptors, KIR3DL2 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: